Epidemiology and associated factors for hospitalization-related respiratory syncytial virus infection among children less than five years of age in Saudi Arabia. A Real-World Retrospective Analysis.
Main Article Content
Keywords
Respiratory Syntical Virus, Hospitalization, RSV-hospitalization, Epidemiology
Abstract
Background: The rapid development, approval, and distribution of these vaccines highlight the need to carefully assess their safety. One significant concern is the incidence of Adverse Events Following Immunization (AEFI). There are few reports on the factors influencing AEFI and differences in AEFI among different COVID-19 vaccine brands in Thailand. Exploration of the incidence and factors related to post-vaccination adverse reactions against SARSCoV- 2 in the population attending vaccination centers in Thailand is considered pivotal. Objective: To investigate the incidence and factors associated with adverse events following the administration of the COVID-19 vaccine in the Ubon Ratchathani province. Methods: We analyzed data from individuals who received COVID-19 vaccinations in Ubon Ratchathani province between June 1, 2021, and July 31, 2022. Results: The study examined data from 2,955,978 COVID-19 vaccines administered in Ubon Ratchathani province. Among these, 3.34% experienced an AEFI, further categorized into events occurring within 30 min (0.17%) and after 30 min (3.19%) of vaccination. The occurrences were higher in females compared to males. The age groups exhibited distinct AEFI rates, with children aged 5–17 years and adults aged 18–60 years facing a higher risk. Additionally, individuals with comorbidities are more likely to experience AEFI. The brand of the vaccine and the number of doses administered also influenced AEFI rates. This comprehensive analysis provides valuable insights into AEFI reports, vaccine brands, and associated risk factors, and offers crucial information for vaccine safety monitoring and management. Conclusion: This COVID-19 vaccine adverse events study revealed that higher odds of adverse events were associated with being female, younger, having comorbidities, brand of vaccines, or getting over two doses. These findings provide valuable real-world safety information regarding different COVID-19 vaccines, aiding healthcare professionals and policymakers in effectively monitoring and managing vaccine-related AEFI.
References
2. Ahmed A, Alsenaidy AM, Mobaireek KF, AlSaadi MM. Viral etiology of acute respiratory infections during 2014–2016 in Riyadh, Saudi Arabia. Future Virology. 2022;17(5):269-80.
3. Dhamotharan J, Kumar DPD, Rajasekaran LRS, Mondal V, Selvan RP, Shaik SAM, et al. Assessing the Quality of Life of Children’s with Acute Respiratory Tract Infections. Indian Journal of Pharmacy Practice. 2021;14(1).
4. Khasawneh AI, Himsawi NM, Abu-Raideh JA, Sammour A, Abu Safieh H, Obeidat A, et al. Prevalence of SARS-COV-2 and other respiratory pathogens among a Jordanian subpopulation during Delta-to-Omicron transition: Winter 2021/2022. PLoS One. 2023;18(3):e0283804. https://doi.org/10.1371/journal.pone.0283804
5. Suryadevara M, Domachowske JB. Epidemiology and seasonality of childhood respiratory syncytial virus infections in the
tropics. Viruses. 2021;13(4):696. https://doi.org/10.3390/v13040696
6. Chorazka M, Flury D, Herzog K, Albrich WC, Vuichard-Gysin D. Clinical outcomes of adults hospitalized for laboratory-confirmed respiratory syncytial virus or influenza virus infection. Plos one. 2021;16(7):e0253161. https://doi.org/10.1371/journal.pone.0253161
7. Hanula RJ. Influenza Therapeutics: Evaluating the Benefits and Harms of Oseltamivir and Corticosteroids: McGill University (Canada); 2022.
8. Alharbi AS, Alzahrani M, Alodayani AN, Alhindi MY, Alharbi S, Alnemri A. Saudi experts’ recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association. Saudi Medical Journal. 2021;42(4):355-362. https://doi.org/10.15537/smj.2021.42.4.20200769
9. Alharbi AS, Alqwaiee M, Al-Hindi MY, Mosalli R, Al-Shamrani A, Alharbi S, et al. Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO). Annals of thoracic medicine. 2018;13(3):127-43. https://doi.org/10.4103/atm.atm_137_18
10. Alharbi A, Yousef A, Zubani A, Alzahrani M, Al-Hindi M, Alharbi S, et al. Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study. Advances in Therapy. 2024: 41(4):1419-35.https://doi.org/10.1007/s12325-024-02798-w
11. Stambas J, Lu C, Tripp RA. Innate and adaptive immune responses in respiratory virus infection: Implications for the clinic. Expert review of respiratory medicine. 2020;14(11):1141-7. https://doi.org/10.1080/17476348.2020.1807945
12. Young M, Smitherman L. Socioeconomic impact of RSV hospitalization. Infectious diseases and therapy. 2021;10(Suppl 1):35-45. https://doi.org/10.1007/s40121-020-00390-7
13. Yassine HM, Sohail MU, Younes N, Nasrallah GK. Systematic review of the respiratory syncytial virus (RSV) prevalence, genotype distribution, and seasonality in children from the Middle East and North Africa (MENA) region. Microorganisms. 2020;8(5):713. https://doi.org/10.3390/microorganisms8050713
14. Na’amnih W, Kassem E, Tannous S, Kagan V, Jbali A, Hanukayev E, et al. Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years. Epidemiology & Infection. 2022;150:e45. https://doi.org/10.1017/s0950268822000152
15. Ramrakhiani NS, Le MH, Yeo YH, Le AK, Maeda M, Nguyen MH. Validity of international classification of diseases, tenth revision, codes for cirrhosis. Digestive diseases. 2021;39(3):243-6. https://doi.org/10.1159/000510981
16. Sharma D, Padmavathi IV, Tabatabaii SA, Farahbakhsh N. Late preterm: a new high risk group in neonatology. The Journal of Maternal-Fetal & Neonatal Medicine. 2021;34(16):2717-30. https://doi.org/10.1080/14767058.2019.1670796
17. Kim L, Garg S, O’Halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated
hospitalization surveillance network (COVID-NET). Clinical infectious diseases. 2021;72(9):e206-e14. https://doi.org/10.1093/cid/ciaa1012
18. Fagbo SF, Garbati MA, Hasan R, AlShahrani D, Al‐Shehri M, AlFawaz T, et al. Acute viral respiratory infections among children in MERS‐endemic Riyadh, Saudi Arabia, 2012–2013. Journal of Medical Virology. 2017;89(2):195-201. https://doi.org/10.1002/jmv.24632
19. Khamis F, Al‐Kobaisi M, Al‐Areimi W, Al‐Kindi H, Al‐Zakwani I. Epidemiology of respiratory virus infections among infants and young children admitted to hospital in Oman. Journal of medical virology. 2012;84(8):1323-9. https://doi.org/10.1002/jmv.23330
20. Coultas JA, Smyth R, Openshaw PJ. Respiratory syncytial virus (RSV): a scourge from infancy to old age. Thorax. 2019;74(10):986-993. https://doi.org/10.1136/thoraxjnl-2018-212212
21. Jadcherla SR, Wang M, Vijayapal AS, Leuthner SR. Impact of prematurity and co-morbidities on feeding milestones in neonates: a retrospective study. Journal of Perinatology. 2010;30(3):201-8. https://doi.org/10.1038/jp.2009.149
22. Cedrone F, Montagna V, Del Duca L, Camplone L, Mazzocca R, Carfagnini F, et al. Epidemiology of Bronchiolitis and Respiratory Syncytial Virus and Analysis of Length of Stay from 2015 to 2022: Retrospective Observational Study of Hospital Discharge Records from an Italian Southern Province before and during the COVID-19 Pandemic. Diseases. 2024;12(1):17. https://doi.org/10.3390/diseases12010017
23. Mondì V, Paolillo P, Bedetta M, Lucangeli N, Picone S. Exploring the adoption of less restricted criteria for respiratory syncytial virus prophylaxis in late preterm infants: insights from a retrospective analysis. Frontiers in Pediatrics. 2023;11:1154518. https://doi.org/10.3389/fped.2023.1154518
24. Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. Journal of Allergy and Clinical Immunology. 2017;139(2):501-7. https://doi.org/10.1016/j.jaci.2016.03.049
25. Pérez-Yarza EG, Moreno A, Lázaro P, Mejías A, Ramilo O. The association between respiratory syncytial virus infection
and the development of childhood asthma: a systematic review of the literature. The Pediatric infectious disease journal. 2007;26(8):733-9. https://doi.org/10.1097/inf.0b013e3180618c42
26. Aikphaibul P, Theerawit T, Sophonphan J, Wacharachaisurapol N, Jitrungruengnij N, Puthanakit T. Risk factors of severe
hospitalized respiratory syncytial virus infection in tertiary care center in Thailand. Influenza and Other Respiratory Viruses. 2021;15(1):64-71. https://doi.org/10.1111/irv.12793
27. Naorat S, Chittaganpitch M, Thamthitiwat S, Henchaichon S, Sawatwong P, Srisaengchai P, et al. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008–2011. The Journal of infectious diseases. 2013;208(suppl_3):S238-S45. https://doi.org/10.1093/infdis/jit456
28. Chuaychoo B, Ngamwongwan S, Kaewnaphan B, Athipanyasilp N, Horthongkham N, Kantakamalakul W, et al. Clinical
manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. Journal of Clinical Virology. 2019;117:103-8. https://doi.org/10.1016/j.jcv.2019.07.001
29. Bunthi C, Baggett HC, Gregory CJ, Thamthitiwat S, Yingyong T, Paveenkittiporn W, et al. Enhanced surveillance for severe pneumonia, Thailand 2010–2015. BMC Public Health. 2019;19(Suppl 3):472. https://doi.org/10.1186/s12889-019-6774-5
30. Turner C, Turner P, Cararra V, Eh Lwe N, Watthanaworawit W, Day NP, et al. A high burden of respiratory syncytial virus associated pneumonia in children less than two years of age in a South East Asian refugee population. PloS one. 2012;7(11):e50100. https://doi.org/10.1371/journal.pone.0050100
31. Jha A, Jarvis H, Fraser C, Openshaw P. Respiratory syncytial virus. SARS, MERS and other viral lung infections. 2016.
32. Lin H-C, Liu Y-C, Hsing T-Y, Chen L-L, Liu Y-C, Yen T-Y, et al. RSV pneumonia with or without bacterial co-infection among healthy children. Journal of the Formosan Medical Association. 2022;121(3):687-93. https://doi.org/10.1016/j.jfma.2021.08.012
33. Epstein D, Nasser R, Mashiach T, Azzam ZS, Berger G. Increased red cell distribution width: a novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease. Respiratory medicine. 2018;136:1-7. https://doi.org/10.1016/j.rmed.2018.01.011
34. Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clinical microbiology reviews. 2017;30(1):277-319. https://doi.org/10.1128/cmr.00010-16
35. Messina A, Germano C, Avellis V, Tavella E, Dodaro V, Massaro A, et al. New strategies for the prevention of respiratory syncytial virus (RSV). Early Human Development. 2022;174:105666. https://doi.org/10.1016/j.earlhumdev.2022.105666
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.